Loading provider…
Loading provider…
Medical Oncology Physician in New York, NY
NPI: 1164816005Primary Practice Location
NEW YORK-PRESBYTERIAN HOSPITAL
5141 Broadway, New York, NY
Primary Employer
Trustees of Columbia University in the City of New York
columbiadoctors.org
HQ Phone
Get M.D., PH.D. Ryan's Phone Numberphone_androidMobile
Get M.D., PH.D. Ryan's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
FL State Medical License
2022
NJ State Medical License
2023 - 2027
NY State Medical License
2017 - 2026

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Medical Oncology
Memorial Sloan Kettering Cancer Center
Fellowship • Hematology and Medical Oncology
2017 - 2021
New York Presbyterian Hospital (Cornell Campus)
Residency • Internal Medicine
2015 - 2017
Perelman School of Medicine - Philadelphia
med.upenn.edu
Medical School
Until 2015
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 30 | 88 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 23 | 41 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 22 | 38 |
| 4 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 22 | 99 |
| 5 | 99205New patient office or other outpatient visit, typically 60 minutes | 17 | 17 |
Regorafenib in Combination with First-Line Chemotherapy for Metastatic Esophagogastric Cancer.
Authors: Avni Desai, Michelle Boyar, Yelena Janjigian, David Kelsen, Mark Schattner, Geoffrey Ku, Laura Tang, David Ilson, Jaclyn Hechtman, Sree Bhavani Chalasani
Journal: Oncologist
Publication Date: 2019-09-30
Stem-Loop Recognition by DDX17 Facilitates miRNA Processing and Antiviral Defense
Authors: Ryan H. Moy, Brian S. Cole, Ari Yasunaga, Beth Gold, Ganesh Shankarling, Andrew Varble, Jerome M. Molleston, Benjamin R. tenOever, Kristen W. Lynch, Sara Cherry
Publication Date: 2014-08
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Biospecimen Collection, DRUG: Fluorouracil, PROCEDURE: Biopsy, DRUG: Irinotecan Hydrochloride, PROCEDURE: Diagnostic Imaging, DRUG: Leucovorin Calcium, DRUG: Elimusertib